Crystal structure of a high affinity PD-L1 binder
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Crystal structure of a high affinity PD-L1 binder
应用场景：
创建时间：
2024-10-23
相关数据集
table1_Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?.docx
Background: Combination therapy with immune checkpoint inhibitors (ICIs) has been widely used for clinical treatment in recent years, which has a better survival benefit. However, not all patients can
NIAID Data Ecosystem100
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and Degradation
Several monoclonal antibodies targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) pathway have been used successfully in anticancer immunotherapy. Inherent limitations of
NIAID Data Ecosystem60
Kinetics and binding affinities of anti-PD-1 antibody to human PD-1 determined by BLI.
Kinetics and binding affinities of anti-PD-1 antibody to human PD-1 determined by BLI.
NIAID Data Ecosystem40
Efficacy of PD-1/PDL-1 inhibitors for ovarian cancer: a systematic review and network meta-analysis
Randomized controlled trials (RCTs) have assessed the efficacy of anti-programmed cell death 1 (PD- 1)/programmed cell death ligand 1 (PD-L1), alone or combined with other therapies, for ovarian cance
DataCite Commons2025-08-12 更新60
IMT-2021-0145 Supplementary Tables
Supplementary Table 1. 1L treatments received by treatment class (N=501) Supplementary Table 2. Reasons for end of follow-up for patients who did not receive 2L treatment Supplementary Table 3. Subgro
Figshare2021-08-04 更新40
